172 related articles for article (PubMed ID: 20381585)
1. Effects of the 5-HT(4) receptor agonist RS67333 and paroxetine on hippocampal extracellular 5-HT levels.
Licht CL; Knudsen GM; Sharp T
Neurosci Lett; 2010 May; 476(2):58-61. PubMed ID: 20381585
[TBL] [Abstract][Full Text] [Related]
2. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.
Míguez JM; Paz-Valiñas L; Míguez I; Aldegunde M
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):378-87. PubMed ID: 12012024
[TBL] [Abstract][Full Text] [Related]
3. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
Sharp T; Umbers V; Gartside SE
Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
[TBL] [Abstract][Full Text] [Related]
4. Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine.
Hajós-Korcsok E; McTavish SF; Sharp T
Eur J Pharmacol; 2000 Oct; 407(1-2):101-7. PubMed ID: 11050296
[TBL] [Abstract][Full Text] [Related]
5. The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice.
De Groote L; Olivier B; Westenberg HG
Eur J Pharmacol; 2002 Mar; 439(1-3):93-100. PubMed ID: 11937097
[TBL] [Abstract][Full Text] [Related]
6. Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice.
Guiard BP; Przybylski C; Guilloux JP; Seif I; Froger N; De Felipe C; Hunt SP; Lanfumey L; Gardier AM
J Neurochem; 2004 Apr; 89(1):54-63. PubMed ID: 15030389
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.
Gardier AM; David DJ; Jego G; Przybylski C; Jacquot C; Durier S; Gruwez B; Douvier E; Beauverie P; Poisson N; Hen R; Bourin M
J Neurochem; 2003 Jul; 86(1):13-24. PubMed ID: 12807420
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
[TBL] [Abstract][Full Text] [Related]
9. Rapid anxiolytic effects of a 5-HT₄ receptor agonist are mediated by a neurogenesis-independent mechanism.
Mendez-David I; David DJ; Darcet F; Wu MV; Kerdine-Römer S; Gardier AM; Hen R
Neuropsychopharmacology; 2014 May; 39(6):1366-78. PubMed ID: 24287720
[TBL] [Abstract][Full Text] [Related]
10. Effect of paroxetine on extracellular serotonin and dopamine levels in the prefrontal cortex.
Nakayama K
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):102-5. PubMed ID: 11819027
[TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
Lucas G; Du J; Romeas T; Mnie-Filali O; Haddjeri N; Piñeyro G; Debonnel G
PLoS One; 2010 Feb; 5(2):e9253. PubMed ID: 20169084
[TBL] [Abstract][Full Text] [Related]
12. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
Barton CL; Hutson PH
Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
[TBL] [Abstract][Full Text] [Related]
14. Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration.
Castro E; Tordera RM; Hughes ZA; Pei Q; Sharp T
J Neurochem; 2003 Jun; 85(6):1480-7. PubMed ID: 12787067
[TBL] [Abstract][Full Text] [Related]
15. [5-HT1B serotonin receptors and antidepressant effects of selective serotonin reuptake inhibitors ].
Gardier AM; Trillat AC; Malagié I; David D; Hascoët M; Colombel MC; Jolliet P; Jacquot C; Hen R; Bourin M
C R Acad Sci III; 2001 May; 324(5):433-41. PubMed ID: 11417564
[TBL] [Abstract][Full Text] [Related]
16. 5-HT4 receptor-mediated modulation of 5-HT release in the rat hippocampus in vivo.
Ge J; Barnes NM
Br J Pharmacol; 1996 Apr; 117(7):1475-80. PubMed ID: 8730742
[TBL] [Abstract][Full Text] [Related]
17. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
Mitchell SN; Greenslade RG; Cooper J
Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
[TBL] [Abstract][Full Text] [Related]
18. Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT.
Gartside SE; Umbers V; Hajós M; Sharp T
Br J Pharmacol; 1995 Jul; 115(6):1064-70. PubMed ID: 7582504
[TBL] [Abstract][Full Text] [Related]
19. 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI).
Hjorth S; Auerbach SB
Behav Brain Res; 1996; 73(1-2):281-3. PubMed ID: 8788519
[TBL] [Abstract][Full Text] [Related]
20. Possible in vivo 5-HT reuptake blocking properties of 8-OH-DPAT assessed by measuring hippocampal extracellular 5-HT using microdialysis in rats.
Assié MB; Koek W
Br J Pharmacol; 1996 Nov; 119(5):845-50. PubMed ID: 8922730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
